Bcl10 is involved in t(1;14)(p22;q32) of MALT B cell lymphoma and mutated in multiple tumor types

被引:554
作者
Willis, TG
Jadayel, DM
Du, MQ
Peng, HZ
Perry, AR
Abdul-Rauf, M
Price, H
Karran, L
Majekodunmi, O
Wlodarska, I
Pan, LX
Crook, T
Hamoudi, R
Isaacson, PG
Dyer, MJS [1 ]
机构
[1] Inst Canc Res, Acad Dept Haematol & Cytogenet, Sutton SM2 5NG, Surrey, England
[2] Inst Canc Res, Canc Gene Cloning Ctr, Sutton SM2 5NG, Surrey, England
[3] Inst Canc Res, Sect Cell Biol & Expt Pathol, Sutton SM2 5NG, Surrey, England
[4] UCL, Sch Med, Dept Histopathol, London WC1E 6JJ, England
[5] Katholieke Univ Leuven, Ctr Human Genet, Louvain, Belgium
[6] Katholieke Univ Leuven VIB, Louvain, Belgium
关键词
D O I
10.1016/S0092-8674(00)80957-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
MALT B cell lymphomas with t(1;14)(p22;q32) showed a recurrent breakpoint upstream of the promoter of a novel gene, Bcl10. Bcl10 is a cellular homolog of the equine herpesvirus-2 E10 gene: both contain an amino-terminal caspase recruitment domain (CARD) homologous to that found in several apoptotic molecules. Bcl10 and E10 activated NF-KB but caused apoptosis of 293 cells. Bcl10 expressed in a MALT lymphoma exhibited a frameshift mutation resulting in truncation distal to the CARD. Truncated Bcl10 activated NF-KB but did not induce apoptosis. Wild-type Bcl10 suppressed transformation, whereas mutant forms had lost this activity and displayed gain-of-function transforming activity. Similar mutations were detected in other tumor types, indicating that Bcl10 may be commonly involved in the pathogenesis of human malignancy.
引用
收藏
页码:35 / 45
页数:11
相关论文
共 46 条
  • [1] ALBERT T, 1994, ONCOGENE, V9, P759
  • [2] BCL-6 PROTEIN IS EXPRESSED IN GERMINAL-CENTER B-CELLS
    CATTORETTI, G
    CHANG, CC
    CECHOVA, K
    ZHANG, JD
    YE, BH
    FALINI, B
    LOUIE, DC
    OFFIT, K
    CHAGANTI, RSK
    DALLAFAVERA, R
    [J]. BLOOD, 1995, 86 (01) : 45 - 53
  • [3] Solution structure of the RAIDD CARD and model for CARD/CARD interaction in caspase-2 and caspase-9 recruitment
    Chou, JJ
    Matsuo, H
    Duan, H
    Wagner, G
    [J]. CELL, 1998, 94 (02) : 171 - 180
  • [4] Prodomain-dependent nuclear localization of the caspase-2 (Nedd2) precursor - A novel function for a caspase prodomain
    Colussi, PA
    Harvey, NL
    Kumar, S
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (38) : 24535 - 24542
  • [5] TRANSCRIPTIONAL ACTIVATION BY P53 CORRELATES WITH SUPPRESSION OF GROWTH BUT NOT TRANSFORMATION
    CROOK, T
    MARSTON, NJ
    SARA, EA
    VOUSDEN, KH
    [J]. CELL, 1994, 79 (05) : 817 - 827
  • [6] RAIDD is a new 'death' adaptor molecule
    Duan, H
    Dixit, VM
    [J]. NATURE, 1997, 385 (6611) : 86 - 89
  • [7] OVERPRODUCTION OF P53 ANTIGEN MAKES ESTABLISHED CELLS HIGHLY TUMORIGENIC
    ELIYAHU, D
    MICHALOVITZ, D
    OREN, M
    [J]. NATURE, 1985, 316 (6024) : 158 - 160
  • [8] WILD-TYPE P53 CAN INHIBIT ONCOGENE-MEDIATED FOCUS FORMATION
    ELIYAHU, D
    MICHALOVITZ, D
    ELIYAHU, S
    PINHASIKIMHI, O
    OREN, M
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (22) : 8763 - 8767
  • [9] An oncogenic form of p53 confers a dominant, gain-of-function phenotype that disrupts spindle checkpoint control
    Gualberto, A
    Aldape, K
    Kozakiewicz, K
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (09) : 5166 - 5171
  • [10] Epstein-Barr virus in nasal lymphomas contains multiple ongoing mutations in the EBNA-1 gene
    Gutiérrez, MI
    Spangler, G
    Kingma, D
    Raffeld, M
    Guerrero, I
    Misad, O
    Jaffe, ES
    Magrath, IT
    Bhatia, K
    [J]. BLOOD, 1998, 92 (02) : 600 - 606